Əsas səhifə

Çap

Əks əlaqə

İnfo
Single dose oral indometacin for acute postoperative pain

Mündəricat

Single dose oral indometacin for acute postoperative pain

Sübutlu məlumatların xülasələri
26.06.2017 • Sonuncu dəyişiklik 26.06.2017
Editors

There is insufficient evidence to assess the benefits and harms of a single dose of orally administered indometacin for postoperative pain relief.

A Cochrane review included one study on the efficacy of a single dose of oral indometacin in treating acute postoperative pain in adults, with a total of 59 subjects. Twenty-seven potential papers were identified, but only one small study of women with post-episiotomy pain met the inclusion criteria.

The dose of indometacin assessed against placebo was 50 mg. The number of patients with at least 50% pain relief at 6 hours was 20 out of 29 (69%) for indometacin and 16 out of 30 (53%) for placebo; i.e., there was no significant difference between treatment and placebo (RR 1.3, 95% confidence interval 0.85 to 1.96).

Ədəbiyyat

  1. Mason L, Edwards J, Moore RA, McQuay HJ. Single dose oral indometacin for the treatment of acute postoperative pain. Cochrane Database Syst Rev 2004 Oct 18;(4):CD004308.